TD Private Client Wealth’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.03K Hold
42
﹤0.01% 1248
2026
Q1
$4.58K Hold
42
﹤0.01% 1182
2025
Q4
$3.41K Hold
42
﹤0.01% 1205
2025
Q3
$3.67K Hold
42
﹤0.01% 1178
2025
Q2
$3.49K Sell
42
-3
-7% -$251 ﹤0.01% 1152
2025
Q1
$3.78K Buy
45
+9
+25% +$837 ﹤0.01% 1121
2024
Q4
$3.32K Buy
36
+7
+24% +$673 ﹤0.01% 1137
2024
Q3
$2.69K Buy
+29
New +$2.51K ﹤0.01% 1156

Other funds holding LMAT

TD Private Client Wealth's LMAT Position: Q2 2026 in Review

TD Private Client Wealth held its LeMaitre Vascular (LMAT) position steady in Q2 2026 at 42 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #1248.

TD Private Client Wealth first reported a position in LMAT in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.58K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • TD Private Client Wealth held 42 shares of LeMaitre Vascular worth $4.03K as of Q2 2026.
  • TD Private Client Wealth left its LeMaitre Vascular share count unchanged in Q2 2026.
  • LeMaitre Vascular made up ﹤0.01% of TD Private Client Wealth's portfolio in Q2 2026, its #1248 holding.
  • TD Private Client Wealth first reported a position in LeMaitre Vascular in Q3 2024 and has held it in 8 quarters since.
  • TD Private Client Wealth's LeMaitre Vascular position peaked at $4.58K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on TD Private Client Wealth's 13F filing for Q2 2026, filed 4 Aug 2026.